VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Biotechnology
Belgian biotech Ablynx has completed the preparation of a pre-clinical package for the novel Nanobody, ALX-1141 in osteoarthritis, a milestone in its collaboration with Merck KGaA (MRK: DE). 22 May 2017
Biotechnology
The shift of Swiss pharma giant Novartis towards the new-age end of biotech has been made evident in an announcement to cut 500 jobs and create 350 others. 19 May 2017
Biotechnology
US healthcare giant Johnson & Johnson’s pharma unit Janssen expects more than 10 of its new ‘blockbuster’ products to be launched or filed for regulatory approval by 2021. 17 May 2017
Pharmaceutical
French drugmaker Ipsen expects its annual sales to exceed 2.5 billion euros ($2.7 billion) in 2020, an increase of around 58% on its 2016 total of 1.58 million euros. 12 May 2017
Generics
Netherlands-incorporated Mylan has unveiled first quarter 2017 results indicating a 24% increase in revenue compared with the same period a year before. 10 May 2017
Pharmaceutical
Valeant Pharmaceuticals International has had to endure a 95% reduction in its share price value in the last two years, but there was finally some encouraging news for investors as the company announced its latest quarterly results. 9 May 2017
Pharmaceutical
There were positive aspects of Almirall’s first quarter financial results but investors are likely to have been most struck by a 10% drop in profits as the company’s share price fell by 4% to 15.93 euros in five hours of trading after the figures were announced on Monday. 8 May 2017
Biotechnology
New York-based Ovid Therapeutics listed on the Nasdaq stock exchange today, pricing its initial public offering of 5 million shares at $15 each. After its first morning’s trading, the price had fallen about 10%. 5 May 2017
Biotechnology
The venture capital arms of Swiss giants Novartis and Roche have invested heavily in a French biotech startup called Vivet Therapeutics. 4 May 2017
Pharmaceutical
Danish diabetes giant Novo Nordisk saw its share price decline by a massive 36% in 2016, but the roots of recovery are evident after it reported its first-quarter results for 2017, sending shares up by 6% in five hours of trading on Wednesday to 281.60 Danish kroner. 3 May 2017
Pharmaceutical
In a hard-hitting expert view piece, Dr Oded Ben-Joseph and Dr Shawn Manning, from investment bank Outcome Capital, advise on how life science companies can achieve shareholder objectives without falling into some common traps. 3 May 2017
Biotechnology
Private company ImCheck Therapeutics has raised 20 million euros ($22 million) to fund research into antibodies involved in the immune system. 3 May 2017
Pharmaceutical
US pharma giant Merck & Co has beaten estimates with its first quarter 2017 sales figures and has raised its revenue and earnings guidance for 2017. 2 May 2017
Pharmaceutical
US pharma giant Pfizer has announced a 1% decline in sales and a 3% increase in earnings per share this quarter, compared with the same period last year. 2 May 2017
Biotechnology
A 22% increase in its net revenue was reported by US biotech Vertex Pharmaceuticals in its financial results for the first quarter of 2017 compared to the same period of 2016. 28 April 2017
Biotechnology
US biotech firm Seattle Genetics has released first quarter financial results showing that 2017 revenues were $109 million, down slightly from the $111 million reported for the same period of 2016. 28 April 2017
Pharmaceutical
French pharma major Sanofi pleased investors with a strong set of financial results for the first quarter of 2017 today, sending its shares 2.2% higher to 87.87 euros by mid-morning. 28 April 2017
Biotechnology
US biotech Celgene slipped by 0.4% in four hours of trading on Thursday to $124.70 after reporting its first quarter financials, reflecting a mixed bag of results. 27 April 2017
Pharmaceutical
In its first quarter financial results statement, Bristol-Myers Squibb has reported revenues of $4.9 billion, up 12% from the same period last year. 27 April 2017
Pharmaceutical
Shares in London-listed AstraZeneca ticked down under 1% this morning as the company released first quarter results showing slower sales, in line with analyst forecasts, down 12% compared with the same period last year, at $5.4 billion. 27 April 2017
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze